Clinical data now available demonstrates the benefit of maintenance therapy in Multiple Myeloma (MM). MM experts Prof Gareth Morgan, Dr Paul Richardson and Prof Antonio Palumbo discuss the results from the latest studies, how the myeloma treatment paradigm is evolving and expected changes to clinical practice.